LENSAR (LNSR) Competitors $12.64 -0.32 (-2.47%) As of 02:55 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock LNSR vs. BFLY, RXST, AVNS, EMBC, DCTH, BVS, KIDS, AXGN, NPCE, and SMLRShould you be buying LENSAR stock or one of its competitors? The main competitors of LENSAR include Butterfly Network (BFLY), RxSight (RXST), Avanos Medical (AVNS), Embecta (EMBC), Delcath Systems (DCTH), Bioventus (BVS), OrthoPediatrics (KIDS), AxoGen (AXGN), NeuroPace (NPCE), and Semler Scientific (SMLR). These companies are all part of the "medical equipment" industry. LENSAR vs. Its Competitors Butterfly Network RxSight Avanos Medical Embecta Delcath Systems Bioventus OrthoPediatrics AxoGen NeuroPace Semler Scientific LENSAR (NASDAQ:LNSR) and Butterfly Network (NYSE:BFLY) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their risk, earnings, media sentiment, analyst recommendations, dividends, valuation, profitability, institutional ownership and community ranking. Do analysts recommend LNSR or BFLY? LENSAR currently has a consensus target price of $15.00, suggesting a potential upside of 18.67%. Butterfly Network has a consensus target price of $4.00, suggesting a potential upside of 64.61%. Given Butterfly Network's stronger consensus rating and higher probable upside, analysts clearly believe Butterfly Network is more favorable than LENSAR.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score LENSAR 0 Sell rating(s) 2 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00Butterfly Network 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00 Does the MarketBeat Community favor LNSR or BFLY? Butterfly Network received 2 more outperform votes than LENSAR when rated by MarketBeat users. Likewise, 72.73% of users gave Butterfly Network an outperform vote while only 37.50% of users gave LENSAR an outperform vote. CompanyUnderperformOutperformLENSAROutperform Votes637.50% Underperform Votes1062.50% Butterfly NetworkOutperform Votes872.73% Underperform Votes327.27% Do institutionals & insiders have more ownership in LNSR or BFLY? 40.2% of LENSAR shares are held by institutional investors. Comparatively, 37.8% of Butterfly Network shares are held by institutional investors. 38.5% of LENSAR shares are held by insiders. Comparatively, 25.2% of Butterfly Network shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term. Is LNSR or BFLY more profitable? LENSAR has a net margin of -34.03% compared to Butterfly Network's net margin of -129.25%. Butterfly Network's return on equity of -42.68% beat LENSAR's return on equity.Company Net Margins Return on Equity Return on Assets LENSAR-34.03% -49.02% -21.12% Butterfly Network -129.25%-42.68%-30.31% Which has more volatility and risk, LNSR or BFLY? LENSAR has a beta of 0.52, indicating that its share price is 48% less volatile than the S&P 500. Comparatively, Butterfly Network has a beta of 2.54, indicating that its share price is 154% more volatile than the S&P 500. Does the media refer more to LNSR or BFLY? In the previous week, LENSAR and LENSAR both had 4 articles in the media. LENSAR's average media sentiment score of 0.82 beat Butterfly Network's score of 0.17 indicating that LENSAR is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment LENSAR 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Butterfly Network 0 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Which has stronger valuation & earnings, LNSR or BFLY? LENSAR has higher earnings, but lower revenue than Butterfly Network. Butterfly Network is trading at a lower price-to-earnings ratio than LENSAR, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioLENSAR$57.07M2.61-$14.38M-$4.85-2.61Butterfly Network$85.63M7.02-$133.70M-$0.29-8.38 SummaryButterfly Network beats LENSAR on 11 of the 17 factors compared between the two stocks. Get LENSAR News Delivered to You Automatically Sign up to receive the latest news and ratings for LNSR and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding LNSR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart LNSR vs. The Competition Export to ExcelMetricLENSARSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$149.05M$4.37B$5.60B$8.62BDividend YieldN/A42.67%5.28%4.18%P/E Ratio-8.6629.0827.2520.00Price / Sales2.6171.08413.35158.30Price / CashN/A51.0838.2534.64Price / Book4.265.827.124.70Net Income-$14.38M$67.63M$3.24B$248.14M7 Day Performance-3.22%0.37%2.71%2.48%1 Month Performance-9.39%15.27%8.93%6.15%1 Year Performance159.02%18.37%31.30%13.59% LENSAR Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)LNSRLENSAR1.2783 of 5 stars$12.64-2.5%$15.00+18.7%+168.3%$149.05M$57.07M-8.66110BFLYButterfly Network2.2785 of 5 stars$2.48flat$4.00+61.3%+169.6%$613.28M$85.63M-5.39460Positive NewsGap UpRXSTRxSight3.2784 of 5 stars$15.30+1.7%$37.90+147.7%-74.1%$611.18M$148.31M-18.43220Positive NewsGap UpAVNSAvanos Medical1.7569 of 5 stars$12.63+1.4%N/A-37.4%$584.06M$689.20M37.154,040Positive NewsEMBCEmbecta4.2801 of 5 stars$9.91+1.2%$19.33+95.1%-18.6%$579.17M$1.08B9.911,900DCTHDelcath Systems3.6278 of 5 stars$15.95-2.6%$24.00+50.5%+132.0%$555.48M$53.85M-11.8160BVSBioventus2.5559 of 5 stars$6.72+0.4%$14.33+113.3%+2.8%$552.01M$567.70M-11.021,200Positive NewsKIDSOrthoPediatrics4.3426 of 5 stars$21.54+1.7%$35.83+66.4%-25.8%$523.14M$212.45M-17.51200AXGNAxoGen2.3643 of 5 stars$10.41-4.7%$22.20+113.3%+37.8%$474.11M$194.52M-32.53450High Trading VolumeNPCENeuroPace3.755 of 5 stars$12.93-1.7%$15.50+19.9%+85.4%$431.31M$84.31M-12.93170Trending NewsAnalyst RevisionSMLRSemler Scientific2.9158 of 5 stars$33.99+3.1%$71.00+108.9%-20.1%$379.06M$49.23M6.92120Options VolumeHigh Trading Volume Related Companies and Tools Related Companies Butterfly Network Competitors RxSight Competitors Avanos Medical Competitors Embecta Competitors Delcath Systems Competitors Bioventus Competitors OrthoPediatrics Competitors AxoGen Competitors NeuroPace Competitors Semler Scientific Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:LNSR) was last updated on 6/12/2025 by MarketBeat.com Staff From Our PartnersTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredBig Changes Coming to Social Security?According to legendary investor Louis Navellier... This new Trump move could soon not only save Social Secu...InvestorPlace | SponsoredSHOCKING: Musk's Pentagon Secret Mission...It's about a harrowing message discovered on December 16, 2024: "美国军方暗杀名单" It's the reason President Tru...Behind the Markets | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding LENSAR, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share LENSAR With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.